Pharmafile Logo

The Specials Laboratory

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – within 24 hours. We provide hospitals with a space and time saving over labelling service, which involves the bespoke design and labelling of medicines. Once set-up, we store your over labelled products and deliver what you want, when you want – again, within 24 hours. And for hospitals, we also offer investigational medicinal product (IMP) manufacturing from our MHRA-licensed sites so we can meet the supply needs of hospital-based clinical trials.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 1 Regents Drive Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
01661 831 811

 Latest Content from PMHub 

Therapy Watch expands oncology and IBD portfolios

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

The new pharma marketing playbook

Do you know about the 5 key areas that must be in your pharma marketing playbook?

Pharma needs to evolve from customer-centricity to stakeholder-centricity

Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders.

How to plan, execute and refine an excellent congress experience

Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the...

How can pharma help the NHS capitalise on its data?

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

Spotlight on Events

Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...